VANNESTE IN PATHOLOGY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VANNESTE IN PATHOLOGY
Largest movements
- Cash +€288,272
up €288,272 (+241%), from €119,468 to €407,740
mainly Net result for the year (+€562,700) and Tax, wage and social debts (+€99,383)
- Current investments +€212,298
up €212,298 (+16.4%), from €1.3m to €1.5m
- Receivables within one year +€28,437
up €28,437 (+9.3%), from €306,664 to €335,101
- Reserves +€411,246
up €411,246 (+21.6%), from €1.9m to €2.3m
of which Distributable reserves: +€373,356
- Tax, wage and social debts +€99,383
up €99,383 (+250%), from €39,689 to €139,072
- Financial income +€423,825
up €423,825 (+2,247%), from €18,860 to €442,685
- Taxes +€125,220
up €125,220 (+110%), from €113,461 to €238,682
- Gross operating margin +€57,930
up €57,930 (+16.8%), from €345,627 to €403,557
- Financial charges +€12,967
up €12,967 (+44.1%), from €29,394 to €42,362
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,960,995 | €2,470,572 | +€509,577 | +26.0% |
| Current assets | 29/58 | €1,960,995 | €2,470,572 | +€509,577 | +26.0% |
| Amounts receivable after more than one year | 29 | €240,352 | €220,813 | -€19,538 | -8.1% |
| Other amounts receivable | 291 | €240,352 | €220,813 | -€19,538 | -8.1% |
| Amounts receivable within one year | 40/41 | €306,664 | €335,101 | +€28,437 | +9.3% |
| Other amounts receivable | 41 | €306,664 | €335,101 | +€28,437 | +9.3% |
| Current investments | 50/53 | €1,292,259 | €1,504,557 | +€212,298 | +16.4% |
| Cash at bank and in hand | 54/58 | €119,468 | €407,740 | +€288,272 | +241% |
| Deferred charges and accrued income | 490/1 | €2,253 | €2,360 | +€107 | +4.8% |
| Total equity and liabilities | 10/49 | €1,960,995 | €2,470,572 | +€509,577 | +26.0% |
| Equity | 10/15 | €1,919,093 | €2,330,339 | +€411,246 | +21.4% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,906,693 | €2,317,939 | +€411,246 | +21.6% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Tax-exempt reserves | 132 | €134,720 | €172,610 | +€37,890 | +28.1% |
| Distributable reserves | 133 | €1,771,973 | €2,145,329 | +€373,356 | +21.1% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €41,902 | €140,233 | +€98,331 | +235% |
| Amounts payable within one year | 42/48 | €41,082 | €139,388 | +€98,306 | +239% |
| Trade debts | 44 | €1,393 | €317 | -€1,077 | -77.3% |
| Suppliers | 440/4 | €1,393 | €317 | -€1,077 | -77.3% |
| Taxes, remuneration and social security | 45 | €39,689 | €139,072 | +€99,383 | +250% |
| Taxes | 450/3 | €39,689 | €139,072 | +€99,383 | +250% |
| Other amounts payable | 47/48 | €0 | - | = | |
| Accrued charges and deferred income | 492/3 | €820 | €845 | +€25 | +3.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €0 | - | = | |
| Other operating charges | 640/8 | €1,485 | €2,498 | +€1,013 | +68.2% |
| Gross operating margin | 9900 | €345,627 | €403,557 | +€57,930 | +16.8% |
| Operating profit (loss) | 9901 | €344,142 | €401,059 | +€56,917 | +16.5% |
| Financial income | 75/76B | €18,860 | €442,685 | +€423,825 | +2,247% |
| Recurring financial income | 75 | €18,860 | €442,685 | +€423,825 | +2,247% |
| Financial charges | 65/66B | €29,394 | €42,362 | +€12,967 | +44.1% |
| Recurring financial charges | 65 | €29,394 | €42,362 | +€12,967 | +44.1% |
| Profit (loss) for the period before taxes | 9903 | €333,608 | €801,382 | +€467,774 | +140% |
| Transfer from deferred taxes | 780 | €0 | - | = | |
| Income taxes | 67/77 | €113,461 | €238,682 | +€125,220 | +110% |
| Profit (loss) for the period | 9904 | €220,147 | €562,700 | +€342,554 | +156% |
| Transfer from tax-exempt reserves | 789 | €99,680 | €0 | -€99,680 | -100% |
| Transfer to tax-exempt reserves | 689 | €0 | €37,890 | +€37,890 | |
| Profit (loss) for the period to be appropriated | 9905 | €319,827 | €524,810 | +€204,984 | +64.1% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.